Search Results - "Laufer, D S"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient? by Fletcher, M A, Laufer, D S, McIntosh, E D G, Cimino, C, Malinoski, F J

    “…Risk factors for invasive pneumococcal disease (IPD) include young and old age, comorbidities (such as splenic dysfunction, immunodeficiencies, chronic renal…”
    Get more information
    Journal Article
  2. 2

    Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems by Laufer, S D, Restle, T

    Published in Current pharmaceutical design (01-12-2008)
    “…Cellular uptake of therapeutic oligonucleotides and subsequent intracellular trafficking to their target sites represents the major technical hurdle for the…”
    Get more information
    Journal Article
  3. 3

    Saliva and Serum as Diagnostic Media for Antibody to Hepatitis A Virus in Adults and in Individuals Who Have Received an Inactivated Hepatitis A Vaccine by Laufer, Dagna S., Hurni, William, Watson, Barbara, Miller, William, Ryan, John, Nalin, David, Brown, Leora

    Published in Clinical infectious diseases (01-04-1995)
    “…Saliva was evaluated as a diagnostic fluid for screening individuals for evidence of previous hepatitis A virus (HAV) infection and for evidence of…”
    Get full text
    Journal Article
  4. 4

    Resistance to antivirals by Laufer, D S, Starr, S E

    Published in The Pediatric clinics of North America (01-06-1995)
    “…The ability of viruses to develop resistance to antiviral agents is already a major concern with respect to HIV. This article reviews mechanisms and clinical…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children by Watson, B M, Laufer, D S, Kuter, B J, Staehle, B, White, C J, Starr, S E

    Published in The Journal of infectious diseases (01-03-1996)
    “…An investigational tetravalent combined measles, mumps, rubella, and varicella vaccine and measles-mumps-rubella and varicella vaccines at separate injection…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Safety and Immunogenicity of a Combined Live Attenuated Measles, Mumps, Rubella, and Varicella Vaccine (MMRIIV) in Healthy Children by Watson, Barbara M., Laufer, Dagna S., Kuter, Barbara J., Staehle, Brenda, White, C. Jo

    Published in The Journal of infectious diseases (01-03-1996)
    “…An investigational tetravalent combined measles, mumps, rubella, and varicella vaccine and measles-mumps-rubella and varicella vaccines at separate injection…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Noncovalent peptide-mediated delivery of chemically modified steric block oligonucleotides promotes splice correction: quantitative analysis of uptake and biological effect by Laufer, Sandra D, Recke, Anna Lena, Veldhoen, Sandra, Trampe, Alexander, Restle, Tobias

    Published in Oligonucleotides (01-03-2009)
    “…Despite numerous encouraging reports in the literature, the efficiency of cell penetrating peptides (CPPs) in promoting cellular delivery of bioactive cargos…”
    Get more information
    Journal Article